JENNA COOPER: Open Payments
NPI 1790883429 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,946 in 87 payments from 36 companies in 2025. Trend: 2023 $1,791 · 2024 $2,291 · 2025 $1,946
Food & beverage: $1,876Education: $70
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 10 | $207 |
| ABBVIE INC. | 7 | $167 |
| HARMONY BIOSCIENCES LLC | 7 | $151 |
| Merz Pharmaceuticals, LLC | 4 | $115 |
| Biogen, Inc. | 6 | $114 |
| JAZZ PHARMACEUTICALS INC. | 5 | $92 |
| Alexion Pharmaceuticals, Inc. | 3 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| UCB, Inc. | 3 | $74 |
| PFIZER INC. | 3 | $71 |
Products named: INGREZZA, Xeomin, LEQEMBI, ULTOMIRIS, BOTOX, WAKIX, HYQVIA, Rystiggo.
Industry payments across AL — which companies pay providers there.
